Literature DB >> 2861375

Ciprofloxacin-resistant Pseudomonas.

C M Roberts, J Batten, M E Hodson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2861375     DOI： 10.1016/s0140-6736(85)91862-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Clinical uses of nalidixic acid analogues: the fluoroquinolones.

Authors:  N Høiby
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

2.  Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.

Authors:  M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

Review 3.  Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

4.  Resistance to quinolones.

Authors:  R P Mouton
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

5.  Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

Authors:  T Jensen; S S Pedersen; N Høiby; C Koch
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

Review 6.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

7.  Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection.

Authors:  C R Marchbanks; J R McKiel; D H Gilbert; N J Robillard; B Painter; S H Zinner; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 8.  Bacterial resistance to fluoroquinolones: lessons to be learned.

Authors:  P Ball
Journal:  Infection       Date:  1994       Impact factor: 3.553

9.  Cloning of multidrug resistance gene pqrA from Proteus vulgaris.

Authors:  H Ishida; H Fuziwara; Y Kaibori; T Horiuchi; K Sato; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 10.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.